Compass Pathways' delayed phase 3 readout for its psilocybin treatment has hit its primary endpoint of reducing the severity of patients’ depression, but investors appear unimpressed. The study ...
Hosted on MSN
Compass Point upgrades PayPal (PYPL) to neutral amid CEO transition, priced-in uncertainty
PayPal Holdings Inc. (NASDAQ:PYPL) is one of the best large cap stocks to buy under $50. On February 3, Compass Point upgraded PayPal to Neutral from Sell with a price target of $51, which was brought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results